ClearPoint Neuro Inc. (CLPT) Launches Proposed Public Offering of Common Stock

ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today the commencement of a proposed underwritten public offering of its shares of common stock. All the shares will be offered by the Company. The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock in an amount of up to 15% of the number of shares sold in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

B. Riley Securities is acting as book-running manager and Lake Street Capital Markets, LLC is acting as co-manager for the proposed offering.

You May Also Be Interested In

• Gorilla Technology prices $125M convertible bond for Indonesia project
• Crescent Biopharma launches public offering of shares and warrants
• NeOnc gets FDA manufacturing feedback for NEO212 tablet transition